How can health care institutions and an organizations like Mayo Clinic move models from research to clinical practice? How can UX help with product realization and implementation of software as medical devices? This presentation will focus on regulatory activities involved in model development and how UX considerations similarly align to risk analysis and mitigation. Who are the target end users of a model (versus benefactors)? What is the model’s intended use? What types of models require regulatory oversight and serious risk mitigation?